glp-1 semaglutide weight loss Options Understanding GLP-1 and Its Role

CagriSema: Phase 3 (REDEFINE program)

Typically, those who should avoid GLP-1s are those with: A personal or family history of certain thyroid cancers Multiple endocrine neoplasia syndrome type 2 A history of pancreatitis Severe gastroparesis (delayed stomach emptying) Pregnancy or plans to become pregnant Additionally, if you have a history of eating disorders, severe depression or unrealistic weight loss expectations, its important to address these concerns with your physician before considering medication

In another study in healthy and obese-diabetic animal models, allulose also elicited a GLP-1 release, reduced food intake and showed positive effects on glucose tolerance (Reference Iwasaki, Sendo and Dezaki17)

Here are answers to our patients most common questions about this weight management solution

S.ThraneK